These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27259806)

  • 21. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
    Waxman AB; Zamanian RT
    Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical therapies for pulmonary arterial hypertension.
    Pulido T; Zayas N; de Mendieta MA; Plascencia K; Escobar J
    Heart Fail Rev; 2016 May; 21(3):273-83. PubMed ID: 26791159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developments in pulmonary arterial hypertension-targeted therapy for chronic thromboembolic pulmonary hypertension.
    Hadinnapola C; Pepke-Zaba J
    Expert Rev Respir Med; 2015 Oct; 9(5):559-69. PubMed ID: 26366805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of treatment goals in paediatric pulmonary arterial hypertension.
    Ploegstra MJ; Douwes JM; Roofthooft MT; Zijlstra WM; Hillege HL; Berger RM
    Eur Respir J; 2014 Dec; 44(6):1616-26. PubMed ID: 25034572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of bosentan combined with vardenafil in the treatment of postoperative pulmonary hypertension in children with congenital heart disease: A protocol of randomized controlled trial.
    Gao C; Liu J; Zhang R; Zhao M; Wu Y
    Medicine (Baltimore); 2021 Jan; 100(1):e23896. PubMed ID: 33429750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases.
    Alves JL; Gavilanes F; Jardim C; Fernandes CJCDS; Morinaga LTK; Dias B; Hoette S; Humbert M; Souza R
    Chest; 2015 Feb; 147(2):495-501. PubMed ID: 25317567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current challenges in pediatric pulmonary hypertension.
    Takatsuki S; Ivy DD
    Semin Respir Crit Care Med; 2013 Oct; 34(5):627-44. PubMed ID: 24037630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Treatments for Pulmonary Arterial Hypertension: Interpreting Outcomes by Network Meta-analysis.
    Badiani B; Messori A
    Heart Lung Circ; 2016 Jan; 25(1):46-52. PubMed ID: 26233257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary hypertension in Russia: the first results of the national register].
    Chazova IE; Arkhipova OA; Valieva ZS; Nakonechnikov SN; Martyniuk TV
    Ter Arkh; 2014; 86(9):56-64. PubMed ID: 25518507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostacyclins and pulmonary arterial hypertension in children.
    Wu Y; Liu HM; Gu L; Li QW; Zhu L
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):37-45. PubMed ID: 35049017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pulmonary arterial hypertension: changing approaches to management].
    Sidorenko BA; Preobrazhenskiĭ DV; Batyraliev TA; Belenkov IuN
    Kardiologiia; 2011; 51(1):100-8. PubMed ID: 21626809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical Treatment of Pulmonary Arterial Hypertension.
    Sahay S; Humbert M; Sitbon O
    Semin Respir Crit Care Med; 2017 Oct; 38(5):686-700. PubMed ID: 29032569
    [No Abstract]   [Full Text] [Related]  

  • 34. Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension.
    Lammi MR; Mathai SC; Saketkoo LA; Domsic RT; Bojanowski C; Furst DE; Steen VD;
    Arthritis Rheumatol; 2016 Mar; 68(3):740-8. PubMed ID: 26479414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eisenmenger syndrome: recent advances in pharmacotherapy.
    Said S; Porres-Aguilar M; Porres-Munoz M; Mukherjee D
    Cardiovasc Hematol Agents Med Chem; 2013 Dec; 11(4):289-96. PubMed ID: 24655213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current issues in pulmonary hypertension].
    Forster T
    Orv Hetil; 2012 Apr; 153(16):603-6. PubMed ID: 22510315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis.
    Sakao S; Tanabe N; Tatsumi K
    J Am Heart Assoc; 2019 Aug; 8(16):e013310. PubMed ID: 31423872
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of Pulmonary Arterial Hypertension in the Pediatric Patient.
    Ezekian JE; Hill KD
    Curr Cardiol Rep; 2019 Nov; 21(12):162. PubMed ID: 31781972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Portopulmonary hypertension.
    Lv Y; Han G; Fan D
    Scand J Gastroenterol; 2016 Jul; 51(7):795-806. PubMed ID: 27002212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Hansmann G; Apitz C
    Heart; 2016 May; 102 Suppl 2():ii67-85. PubMed ID: 27053700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.